Home > Publications . Search All . Browse All . Country . Browse PSC Pubs . PSC Report Series

PSC In The News

RSS Feed icon

Singh discusses her research in India on infertility

Johnston concerned declines in teen smoking threatened by e-cigarettes

Frey discusses book Diversity Explosion

Highlights

Apply for 2-year NICHD Postdoctoral Fellowships that begin September 2015

PSC Fall 2014 Newsletter now available

Martha Bailey and Nicolas Duquette win Cole Prize for article on War on Poverty

Michigan's graduate sociology program tied for 4th with Stanford in USN&WR rankings

Next Brown Bag

Monday, Jan 12
Filiz Garip, Changing Dynamics of Mexico-U.S. Migration

Cost-effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression

Archived Abstract of Former PSC Researcher

Katon, W., J. Unutzer, M.Y. Fan, J.W. Williamn, Michael Schoenbaum, E. H B Lin, and E.M. Hunkeler. 2006. "Cost-effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression." Diabetes Care, 29(2): 265-270.

OBJECTIVE - To determine the incremental cost-effectiveness and net benefit of a depression collaborative care program compared with usual care for patients with diabetes and depression. RESEARCH DESIGN AND METHODS - This article describes a preplanned subgroup analysis of patients with diabetes from the Improving Mood-Promoting Access to Collaborative (IMPACT) randomized controlled trial. The setting for the study included 18 primary care clinics from eight health care organizations in five states. A total of 418 of 1,801 patients randomized to the IMPACT intervention (n = 204) versus usual care (n = 214) had coexisting diabetes. A depression care manager offered education, behavioral activation, and a choice of problem-solving treatment or support of antidepressant management by the primary care physician. The main outcomes were incremental cost-effectiveness and net benefit of the program compared with usual care. RESULTS - Relative to usual care, intervention patients experienced 115 (95% CI 72 - 159) more depression-free days over 24 months. Total outpatient costs were $25 (95% CI - 1,638 to 1,689) higher during this same period. The incremental cost per depression-free day was 25 cents (-$14 to $15) and the incremental cost per quality-aqjusted life year ranged from $198 . (144-316) to $397 (287 - 641). An incremental net benefit of $1,129 (692 - 1,572) was found. CONCLUSIONS - The IMPACT intervention is a high-value investment for older adults with diabetes; it is associated with high clinical benefits at no greater cost than usual care.

DOI:10.2337/diacare.29.02.06.dc05-1572 (Full Text)

Browse | Search : All Pubs | Next